
Pharma News
-
Divi's Labs to spend Rs. 15-bn to expand manufacturing capacity
2018-11-07Divi's Labs to spend Rs. 15-bn to expand manufacturing capacity
-
Aurobindo recalls hypertensive drug in US
2018-11-06Aurobindo Pharma has initiated voluntary recall of 22 batches of drug substance Irbesartan, used in treatment of hypertension from the US market due to the presence of an impurity, which is believed to cause cancer, the US Food and Drug Administration has
-
Natco Pharma posts over two-fold jump in Q2 PAT to ₹ 181.6 crore
2018-11-06Natco Pharma reported over two-fold increase in consolidated profit after tax at ₹ 181.6 crore for the second quarter ended September 30, 2018. The company had posted a consolidated profit after tax of ₹ 84.4 crore in the same quarter last fiscal, Natco P
-
Amazing Monthly Sales Performance of Opdivo and Keytruda in China
2018-11-06It was revealed that by September 30, i.e., about one month after the marketing in China, the sales revenue of the two anti-PD-1 monoclonal antibody drugs: Opdivo and Keytruda separately reached RMB 190 million and RMB 150 million, showing amazing perform
-
Link between early antibiotic exposure and weight gain in young children
2018-11-05A study conducted within the National Patient Centered Clinical Research Network (PCORnet) has found that antibiotic use at less than 24 months of age was associated with slightly higher body weight at 5 years of age.
-
GSK's anti-seizure drug shows promise in early depression study
2018-11-05Researchers have found that GlaxoSmithKline’s ezogabine(Potiga), approved by the FDA in 2011 as an anti-seizure therapy, could have applications as a treatment for treatment-resistant depression.
-
Reliance Industries posts 17% increase in consolidated Q2 net profit
2018-11-05The consolidated net profit of Reliance Industries Ltd. (RIL) rose 17.4 per cent in the July-September quarter to Rs. 9,516-crore from a year ago as revenue from operations jumped 54.5 per cent to Rs. 1,56,291-crore. The consolidated net profit was Rs. 8,
-
FDA approves Colorcon’s iron oxide petition to expand colour spectrum
2018-11-05FDA approves Colorcon’s iron oxide petition to expand colour spectrum
-
Radhesh Welling appointed as Managing Director, Navin Fluorine
2018-11-05The Board of Directors of Navin Fluorine International Ltd. (NFIL) have, at their meeting held on October 22, 2018, approved the appointment of Mr. Radhesh Welling as Managing Director of the company for a period of five years with effect from December 11
-
PolyOne expands Pune plant with new TPE line and Technology Centre
2018-11-05PolyOne has announced the opening of a new, state-of-the-art thermoplastic elastomer (TPE) production line at its Pune facility. In addition, the company opened a new Technology Centre that will house an advanced laboratory for new and existing R&D ac
-
Hindustan Zinc ranked at top in sustainability index
2018-11-05Hindustan Zinc Ltd. (HZL), a Vedanta Group company and India’s only integrated zinc-lead-silver producer, has announced that it has been ranked first in Environment category and overall fifth in the Metals & Mining sector by the Dow Jones Sustainabili
-
Alembic announces successful USFDA inspection at joint venture
2018-11-05Aleor was formed in April 2016 to develop, manufacture and commercialise dermatology products for worldwide markets. Till date the company has filed six ANDAs.
-
PIL seeks curbs on antibiotics sale without prescription
2018-11-05A Mumbai-based lawyer has filed a public interest litigation (PIL) before the Bombay High Court seeking a directive to restrict over-the-counter sale of antibiotics in India, the world’s “largest consumer of antibiotics”.
-
Suven presents Alzheimer drug findings in Barcelona
2018-11-01Suven presents Alzheimer drug findings in Barcelona
-
SCHOTT Tubing India to boost capacity at Gujarat facility
2018-11-01SCHOTT Tubing India to boost capacity at Gujarat facility
-
PIL seeks curbs on antibiotics sale without prescription
2018-11-01PIL seeks curbs on antibiotics sale without prescription
-
Dr. Reddy's receives approval for aspirin and extended-release dipyridamole
2018-11-01Dr. Reddy's receives approval for aspirin and extended-release dipyridamole
-
Big pharma companies plan cheaper alternatives for Ayushman Bharat insurance
2018-11-01Big pharma companies plan cheaper alternatives for Ayushman Bharat insurance
-
Alembic Pharmaceuticals posts strong Q2 results
2018-11-01Alembic Pharmaceuticals posts strong Q2 results
-
Alembic announces successful USFDA inspection at joint venture
2018-11-01Alembic announces successful USFDA inspection at joint venture
-
Pharmaceutical Industry Overview
The magazine has been officially published in August 2024 and will be distributed at CPHI Korea 2024 and CPHI Milan 2024. It could be permanently available for download online. We sincerely invite you to join us in the publicity, making full use of the influence of the journal to promote your brand & products, expand your corporate influence in the global market.Published in: Aug. 2024
Hot News
-
Top 10 Global CDMO Rankings in 2022
-
Sanofi and Translate Bio mRNA COVID-19 vaccine candidate induced high antibody
-
Forecast of TOP 10 global best-selling drugs in 2021
-
Lilly's GLP-1 and Tirzepatide initiates phase III clinical trial
-
COVID-19 vaccine AZD1222 clinical trials resumed in the UK
-
China State Drug Administration officially approved Semaglutide for type 2 diabetes
-
Top 30 best-selling oncology drugs in the world in 2020
-
Breaking News! China's First KRAS G12D Inhibitor Approved for Clinical Use
-
Pfizer and BioNTech propose expansion of pivotal COVID-19 vaccine trial
-
AbbVie's blockbuster product for atopic dermatitis, Upadacitinib, has been approved for marketing in the EU and Japan